Home › Research › Inflammation and the immune system
Monoamine Oxidase‐B (MAO‐B) Identifies Neurotoxic Reactive Astrocytes in Alzheimer's Disease and Related Dementias
Methasit Jaisa-aad, Cinthya Agüero, Neus Rabaneda‐Lombarte, Celia Bianco, Alexandra N. Melloni, Bradley T. Hyman, Teresa Gómez‐Isla, Pedro Brugarolas et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Compared to controls, MAO-B immunoreactive area fraction was significantly increased in the frontal cortex and white matter of AD, CBD, and especially PiD and FTLD-TDP, but not PSP. MAO-B area fraction correlated positively with that of GFAP and YKL-40. MAO-B was primarily expressed by cortical astrocytes across AD/ADRD and, as expected, colocalized with their mitochondria. As reported for other reactive markers, tufted astrocytes in PSP tended to have low MAO-B levels. Importantly, multivariable linear regression analysis revealed a significant negative association between MAO-B area fraction and cortical thickness even after adjusting for Aβ, pTau or pTDP43 burdens. MAO-B up-regulation may identify the subset of reactive neurotoxic astrocytes in AD/ADRD. Multimodal PET-MRI studies are needed to test the hypothesis that MAO-B radioligand binding predicts future neurodegeneration in individuals with AD/ADRD.
What this study adds
Evidence grade: Low
The record lists 20 participants. In brain tissue from people who died with Alzheimer's disease and related dementias, MAO-B was increased in cortical astrocytes and was negatively associated with cortical thickness even after adjusting for amyloid, pTau or pTDP43 burden. This is tissue-based biomarker research, and the authors state that PET-MRI studies are still needed to test whether MAO-B predicts future neurodegeneration.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jaisa-aad, M., Agüero, C., Rabaneda‐Lombarte, N., Bianco, C., Melloni, A. N., Hyman, B. T., et al. (2025). Monoamine Oxidase‐B (MAO‐B) Identifies Neurotoxic Reactive Astrocytes in Alzheimer's Disease and Related Dementias. Alzheimer s & Dementia. https://doi.org/10.1002/alz70855_102019
Vancouver
Jaisa-aad M, Agüero C, Rabaneda‐Lombarte N, Bianco C, Melloni AN, Hyman BT, et al. Monoamine Oxidase‐B (MAO‐B) Identifies Neurotoxic Reactive Astrocytes in Alzheimer's Disease and Related Dementias. Alzheimer s & Dementia. 2025. doi:10.1002/alz70855_102019. PMID: 41436365.
BibTeX
@article{jaisaaad2025-41436365,
author = {Jaisa-aad, Methasit and Agüero, Cinthya and Rabaneda‐Lombarte, Neus and Bianco, Celia and Melloni, Alexandra N. and Hyman, Bradley T. and Gómez‐Isla, Teresa and Brugarolas, Pedro and others},
title = {{Monoamine Oxidase‐B (MAO‐B) Identifies Neurotoxic Reactive Astrocytes in Alzheimer's Disease and Related Dementias}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70855_102019},
pmid = {41436365},
url = {https://doi.org/10.1002/alz70855_102019}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Compared to controls, MAO-B immunoreactive area fraction was significantly increased in the frontal cortex and white matter of AD, CBD, and especially PiD and FTLD-TDP, but not PSP.
- MAO-B area fraction correlated positively with that of GFAP and YKL-40.
- MAO-B was primarily expressed by cortical astrocytes across AD/ADRD and, as expected, colocalized with their mitochondria.
- As reported for other reactive markers, tufted astrocytes in PSP tended to have low MAO-B levels.
- Importantly, multivariable linear regression analysis revealed a significant negative association between MAO-B area fraction and cortical thickness even after adjusting for Aβ, pTau or pTDP43 burdens.
Why it matters
In brain tissue from people who died with Alzheimer's disease and related dementias, MAO-B was increased in cortical astrocytes and was negatively associated with cortical thickness even after adjusting for amyloid, pTau or pTDP43 burden. This is tissue-based biomarker research, and the authors state that PET-MRI studies are still needed to test whether MAO-B predicts future neurodegeneration.
Study details
- Participants20
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 20 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Alberto Serrano‐Pozo: h-index 46 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41436365) |
| Free to read | 2 / 2 | Free to read |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70855_102019
- PubMed: 41436365
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Inflammation and the immune system from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.